Hutson AD, Fishbein L, O'Brien P, Stacpoole, PW. Accounting for plasma levels below detection limits in a one-compartment zero-order absorption pharmacokinetics model. J APPL STAT. 2002 Nov; 29(8): 1181-1190.
Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease. Virology. 2002 Jan 5; 292(1):137-49.
O'Brien PO, Grieninger B, Nash K, Goodenow MM, Dunn BM. Gag-pol polyprotein processing in HIV patient variants prior to therapy. FASEB JOURNAL. 2001 Mar 8; 15 (5): A907-A907 Part 2, Abstract.
Fishbein L*, O'Brien P*, Hutson A, Theriaque D, Stacpoole PW, Flotte T. Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. J Investig Med. 2000 Nov; 48(6):435-40. *Equal contributors to work
Fishbein L*, O'Brien P*, Hutson A, Theriaque D, Stacpoole P, Flotte T. Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. FASEB JOURNAL. 1999 March 15; 13 (5): A809-A809 Part 2 Suppl. S, Abstract. *Equal contributors to work
Bonner JC, Rice AB, Lindroos PM, O'Brien PO, Dreher KL, Rosas I, Alfaro-Moreno E, Osornio-Vargas AR. Induction of the lung myofibroblast PDGF receptor system by urban ambient particles from Mexico City. Am J Respir Cell Mol Biol. 1998 Oct; 19(4):672-80.